Chronic News and Research

RSS

Researchers take major step forward in understanding causes of CRPS

Researchers at the University of Liverpool have taken a major step forward in understanding the causes of a disorder which causes chronic pain in sufferers.

2 Jul 2014

Isis Pharmaceuticals gets $1 million from GSK to discover and develop drugs for HBV

Isis Pharmaceuticals, Inc. announced today that it has earned a $1 million payment from GlaxoSmithKline related to the advancement of its program to develop antisense drugs to treat hepatitis B virus (HBV).

2 Jul 2014

Arthritis Foundation raises public awareness about juvenile arthritis

Juvenile arthritis (JA) is one of the most common, chronic childhood diseases in the U.S., affecting nearly 300,000 children. During Juvenile Arthritis Awareness Month, the Arthritis Foundation raises public awareness about this painful and debilitating disease—a disease that currently has no cure and can affect children for a lifetime.

2 Jul 2014

Exome sequencing improves diagnosis of mitochondrial disease

Use of exome sequencing improved the ability to identify the underlying gene mutations in patients with biochemically defined defects affecting multiple mitochondrial respiratory chain complexes (enzymes that are involved in basic energy production), according to a study in the July 2 issue of JAMA.

2 Jul 2014

Extract of Chinese herb thunder god vine suppresses pancreatic cancer cell

A diagnosis of pancreatic cancer—the fourth most common cause of cancer death in the U.S.—can be devastating. Due in part to aggressive cell replication and tumor growth, pancreatic cancer progresses quickly and has a low five-year survival rate (less than 5 percent).

1 Jul 2014

Use of catheter ablation lowers risk for atrial fibrillation

Use of catheter ablation is not only beneficial for treating atrial flutter but also can significantly reduce hospital visits - both inpatient and emergency - and lower the risk for atrial fibrillation, according to research by UC San Francisco.

1 Jul 2014

Bone marrow transplantation shows promising results among patients with severe sickle cell disease

Use of a lower intensity bone marrow transplantation method showed promising results among 30 patients (16-65 years of age) with severe sickle cell disease, according to a study in the July 2 issue of JAMA.

1 Jul 2014

LINX Reflux Management System safe for patients suffering from GERD, shows new data

Torax Medical today announced the release of new data from two leading U.S. medical centers that further establishes the LINX Reflux Management System as a safe and effective procedure for patients suffering from gastroesophageal reflux disease (GERD).

1 Jul 2014

Kinetic Concepts' CelluTome Epidermal Harvesting System now commercially available in Europe

Kinetic Concepts, Inc. today launched its CelluTome Epidermal Harvesting System in Europe. The CelluTome System provides an automated, precise and reproducible process of harvesting autologous epidermal tissue for grafting that has been shown to aid closure of acute and chronic wounds.

1 Jul 2014

Wyatt Technology highlights protein-protein interactions study investigated by dynamic light scattering

Wyatt Technology Corporation, the world leader in absolute macromolecular characterization instrumentation, is pleased to highlight a study recently authored by Martin Skov Neergaard from the Faculty of Health and Medical Sciences at the University of Copenhagen, “Protein-Protein Interactions Investigated by DLS: Determination at High and Low Protein Concentration.”

From Waters | Wyatt Technology 1 Jul 2014

Former Procter & Gamble CEO tapped to turn around VA system

President Barack Obama highlighted Robert McDonald's management experience at P&G more than his military career as an Army Ranger in the 82nd Airborne Division.

1 Jul 2014

Obama to name former P&G chief to head VA

The president is expected today to nominate Bob McDonald, a West Point graduate and former CEO of Procter & Gamble.

1 Jul 2014

First Edition: Tuesday, July 1, 2014

Today's early morning highlights from the major news organizations, including numerous reports about the Supreme Court's decision on the health law's contraception mandate and its effect for coverage and on national politics.

1 Jul 2014

CTI completes recruitment in PERSIST-1 clinical trial of pacritinib for treatment of myelofibrosis

CTI BioPharma Corp. announced today that it has completed recruitment in the PERSIST-1 pivotal Phase 3 clinical trial of pacritinib, a novel oral JAK2/FLT3 inhibitor that is being evaluated for the treatment of myelofibrosis.

From Baxter International Inc. 1 Jul 2014

HIV-positive people with early-stage cancer less likely to get cancer treatment

HIV-infected people diagnosed with cancer are two to four times more likely to go untreated for their cancer compared to uninfected cancer patients, according to a new, large retrospective study from researchers in Penn Medicine's Abramson Cancer Center and the National Cancer Institute (NCI) published online ahead of print in the Journal of Clinical Oncology.

1 Jul 2014

Concerns rise about delays in getting generic drugs to market

PBS NewsHour explores concerns that settlements on patents for drugs sometimes delay the generic version getting to consumers.

1 Jul 2014

BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma

BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that the first patient has been enrolled in the U.S. into a FDA Phase 1/2a clinical trial with Eye-D, the company's controlled-release latanoprost insert for the treatment of glaucoma.

1 Jul 2014

Merck reports results from global EMEND Phase 3 study for CINV prevention in pediatric cancer patients

Merck, known as MSD outside the United States and Canada, today announced results from a global, investigational Phase 3 study to evaluate the safety and efficacy of EMEND (aprepitant) in the prevention of chemotherapy-induced nausea and vomiting (CINV) in pediatric cancer patients, aged 6 months to 17 years.

30 Jun 2014

Omega-3 PUFAs offer an affordable way to reduce effects of traumatic brain, spinal cord injuries

The omega-3 polyunsaturated fatty acids (PUFAs) found in seafood and marine oils called EPA and DHA may offer a simple, affordable way to reduce the effects of traumatic brain and spinal cord injuries by decreasing inflammation and nerve cell damage.

30 Jun 2014

Glenridge HealthCare Solutions acquired by WhiteGlove Health

WhiteGlove Health, Inc., a leading chronic care and population health management provider, announced the acquisition of Glenridge HealthCare Solutions, a premier provider of technology-enabled network development and consulting services.

30 Jun 2014

Chronic News and Research

Researchers take major step forward in understanding causes of CRPS

Isis Pharmaceuticals gets $1 million from GSK to discover and develop drugs for HBV

Arthritis Foundation raises public awareness about juvenile arthritis

Exome sequencing improves diagnosis of mitochondrial disease

Extract of Chinese herb thunder god vine suppresses pancreatic cancer cell

Use of catheter ablation lowers risk for atrial fibrillation

Bone marrow transplantation shows promising results among patients with severe sickle cell disease

LINX Reflux Management System safe for patients suffering from GERD, shows new data

Kinetic Concepts' CelluTome Epidermal Harvesting System now commercially available in Europe

Wyatt Technology highlights protein-protein interactions study investigated by dynamic light scattering

Former Procter & Gamble CEO tapped to turn around VA system

Obama to name former P&G chief to head VA

First Edition: Tuesday, July 1, 2014

CTI completes recruitment in PERSIST-1 clinical trial of pacritinib for treatment of myelofibrosis

HIV-positive people with early-stage cancer less likely to get cancer treatment

Concerns rise about delays in getting generic drugs to market

BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma

Merck reports results from global EMEND Phase 3 study for CINV prevention in pediatric cancer patients

Omega-3 PUFAs offer an affordable way to reduce effects of traumatic brain, spinal cord injuries

Glenridge HealthCare Solutions acquired by WhiteGlove Health

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News